Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer

Shorter time from leukapheresis to infusion of axi-cel corresponds to better CR and OS in r/r LBCL patients

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML

Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery

Updates from TAILORx and RxPONDER: Implications for practice

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery

What is required to advance data ethics, data sharing, and Open Science across LMICs

HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC

Initiatives in monitoring of cancer screening in low- and middle-income countries

Cancer control in Latin America

Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project

Genomic testing: Australian model for unlocking the potential of precision oncology for patients and health systems